{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:43:36Z","timestamp":1781142216365,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.idcr.2022.e01412","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T12:26:54Z","timestamp":1642768014000},"page":"e01412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["High doses of favipiravir in two men survivors of Ebola virus disease carrying Ebola virus in semen in Guinea"],"prefix":"10.1016","volume":"27","author":[{"given":"Philippine","family":"Eloy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Laou\u00e9nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdoul Habib","family":"Beavogui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakoba","family":"Keita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Manchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Etard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daouda","family":"Sissoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"France","family":"Mentr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Malvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.idcr.2022.e01412_bib1","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF01734141","article-title":"[Spermatogenic transmission of the \u201cMarburg virus\u201d. (Causes of \u201cMarburg simian disease\u201d)]","volume":"46","author":"Martini","year":"1968","journal-title":"Klin Wochenschr"},{"issue":"25","key":"10.1016\/j.idcr.2022.e01412_bib2","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1509773","article-title":"Molecular evidence of sexual transmission of Ebola virus","volume":"373","author":"Mate","year":"2015","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.idcr.2022.e01412_bib3","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1093\/cid\/cix210","article-title":"Dynamics of Ebola RNA persistence in semen: a report from the postebogui cohort in Guinea","volume":"64","author":"Subtil","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idcr.2022.e01412_bib4","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/S2214-109X(16)30243-1","article-title":"Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study","volume":"5","author":"Sissoko","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.idcr.2022.e01412_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005389","article-title":"Favipiravir pharmacokinetics in Ebola-infected patients of the JIKI trial reveals concentrations lower than targeted. Horby PW, \u00e9diteur","volume":"11","author":"Nguyen","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.idcr.2022.e01412_bib6","unstructured":"Japanese Pharmaceuticals and Medical Devices Agency (PMDA). Report on the Deliberation Results (English version) [Internet]; 2014. Available: \u3008https:\/\/www.pmda.go.jp\/files\/000210319.pdf\u3009."},{"key":"10.1016\/j.idcr.2022.e01412_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.antiviral.2014.01.012","article-title":"Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model","volume":"104","author":"Smither","year":"2014","journal-title":"Antivir Res"},{"issue":"12","key":"10.1016\/j.idcr.2022.e01412_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006034","article-title":"QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient. Schibler M, \u00e9diteur","volume":"11","author":"Chinello","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.idcr.2022.e01412_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008259","article-title":"The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers","volume":"14","author":"Malvy","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"10.1016\/j.idcr.2022.e01412_bib10","doi-asserted-by":"crossref","first-page":"866","DOI":"10.5414\/CP202388","article-title":"Lack of effect of favipiravir, a novel antiviral agent, on QT interval in healthy Japanese adults","volume":"53","author":"Kumagai","year":"2015","journal-title":"Int J Clin Pharm Ther"},{"key":"10.1016\/j.idcr.2022.e01412_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2017.12.021","article-title":"Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus","volume":"151","author":"Bixler","year":"2018","journal-title":"Antivir Res"},{"issue":"3","key":"10.1016\/j.idcr.2022.e01412_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002535","article-title":"Antiviral efficacy of favipiravir against Ebola virus: a translational study in cynomolgus macaques","volume":"15","author":"Guedj","year":"2018","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.idcr.2022.e01412_bib13","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s40262-015-0364-1","article-title":"Ebola virus infection: review of the pharmacokinetic and pharmacodynamic properties of drugs considered for testing in human efficacy trials","volume":"55","author":"Madelain","year":"2016","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.idcr.2022.e01412_bib14","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1038\/s41598-018-25780-3","article-title":"Favipiravir (T-705) protects against Nipah virus infection in the hamster model","volume":"8","author":"Dawes","year":"2018","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.idcr.2022.e01412_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002804","article-title":"Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (Favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever. Singh SK, \u00e9diteur","volume":"8","author":"Oestereich","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"10.1016\/j.idcr.2022.e01412_bib16","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.3201\/eid2607.200275","article-title":"Clinical management of argentine hemorrhagic fever using ribavirin and favipiravir, Belgium, 2020","volume":"26","author":"Veliziotis","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.idcr.2022.e01412_bib17","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s41467-021-21992-w","article-title":"Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model","volume":"12","author":"Driouich","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.idcr.2022.e01412_bib18","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/infdis\/jiab361","article-title":"Molnupiravir inhibits replication of the emerging SARS-CoV-2 variants of concern in a hamster infection model","volume":"224","author":"Abdelnabi","year":"2021","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.idcr.2022.e01412_bib19","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cmi.2020.05.019","article-title":"Review of trials currently testing treatment and prevention of COVID-19","volume":"26","author":"Fragkou","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.idcr.2022.e01412_bib20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/cpt.1877","article-title":"Dose rationale for favipiravir use in patients infected with SARS-CoV-2","volume":"108","author":"Eloy","year":"2020","journal-title":"Clin Pharm Ther"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250922000403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250922000403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:05:40Z","timestamp":1761998740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250922000403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":20,"alternative-id":["S2214250922000403"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2022.e01412","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High doses of favipiravir in two men survivors of Ebola virus disease carrying Ebola virus in semen in Guinea","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2022.e01412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e01412"}}